Autres langues Actavia Life Sciences, Inc.

Actions

RASP

US7538881068

Marché Fermé - OTC Markets Autres places de cotation 18:28:19 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,0173 ^USD	+121,79%		-.--%	+124,68%

16/02	Actavia Life Sciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI
05/01	Actavia Life Sciences, Inc. annonce ses résultats pour l'exercice clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	10/04
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	16/02
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	05/01
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/08/23
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15/05/23
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02/03/23
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	02/03/23
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	09/02/23
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	09/02/23
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	09/02/23
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	24/01/23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23/01/23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20/12/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/08/22
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22/08/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/06/22
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	21/06/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/06/22
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	16/06/22
Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)	10/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Actavia Life Sciences, Inc.

Actions

RASP

US7538881068

Autres langues

Filtres